- Weill Cornell Medical College
- Award Date:
- To study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus.
Open Philanthropy recommended a grant of $220,553 to the Weill Cornell Medical College of Cornell University to enable postdoctoral researcher Ria Goswami and Dr. Sallie Permar to collaborate with researchers at Duke University and UC Davis to study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus.
This follows Open Philanthropy's May 2020 support for earlier phases of the study at Duke University and falls within Open Philanthropy's work on scientific research, specifically within its interest in science supporting biosecurity and pandemic preparedness.